Dermatitis News

Xycrobe Therapeutics announced it has entered into a research agreement with Johnson & Johnson Consumer focusing on application of Xycrobe’s technology for the treatment of inflammatory skin diseases.

Study findings that there were no major differences in the rates of postoperative surgical site infection in outpatient cutaneous surgical procedures performed with sterile gloves vs. nonsterile gloves was among the most-read articles of the past week on Healio.com/Dermatology.

A literature review finding that autologous fat grafting achieved cosmetic breast augmentation with satisfactory levels of volume retention in some studies was among the most-read articles of the past week on Healio.com/Dermatology.

Menlo Therapeutics announced it has signed a license agreement with Japan Tobacco and Torri Pharmaceutical Co. for developing and commercializing serlopitant for treating pruritus in Japan.

A new scleroderma body concealment scale has been developed by the Canadian Scleroderma Research Group as an index of social avoidance by patients with systemic sclerosis, according to a recently published report.

Research finding that patients with psoriasis being treated with Remicade had no significant change in clinical response when switching to an infliximab biosimilar was among the most-read articles of the past week on Healio.com/Dermatology.

Atopic dermatitis increases the risks for short-term and long-term systemic comorbidities, according to information presented at the American Academy of Dermatology Summer Meeting in Boston.

Study findings that incidence of melanoma in situ increased at a faster rate than invasive melanoma was among the most-read articles of the past week on Healio.com/Dermatology.

Study results finding that Kybella demonstrated efficacy in treating submental fat, and may be an alternative to surgical treatment, was among the most-read articles of the past week on Healio.com/Dermatology.

Children with atopic diseases such as asthma, allergic rhinitis, or eczema, and those whose parents who were exposed to attention-deficit/hyperactivity disorder and atopic disease medications, were more susceptible to developing ADHD, according to study results.